Feasibility and Safety of the Augmented Reality Guidance Software TAVIPILOT Software During Transcatheter Aortic Valve Replacement (TAVR/TAVI) in Australia

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorCaranx Medical

About this trial

The TAVIPILOT Software by Caranx Medical is an advanced intraoperative assistance tool designed to enhance the accuracy of transcatheter aortic valve positioning during TAVI. It works alongside conventional fluoroscopy, using real-time image analysis to provide precise anatomical landmarks. TAVIPILOT Software detects key anatomical structures, tracks valve positioning, and uses AI-based confidence indicators to assist in alignment. The software is compatible with approved C-arm imaging systems and specific catheter models.

The objective is to assess the feasibility and safety of the TAVIPILOT Software augmented reality guidance software during TAVI procedures, aiming to improve valve positioning precision and, implicitly and to reduce implantation depth variations.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged ≥65

Indicated for transfemoral TAVR for severe aortic stenosis

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

  • TAVR using a guidance software

    Device

    TAVR procedure with TAVIPILOT augmented reality guidance software operating during the procedure, enabling clinicians to assess the live analysis and recommendations provided by the software.

Treatment groups

10 Participants
are divided into 1 treatment group
Group A: Experimental: TAVR procedure with TAVIPILOT Software (investigational medical device)Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Investigational device-related safety

The primary objective is to evaluate investigational device-related safety, including the occurrence of investigational device-related conversion to open-heart surgery, investigational device-related valve embolization.

Time frame
Periprocedural
2

Investigational device-related safety

The investigational device-related safety will also be assessed by verifying the absence of major technical malfunctions.

Time frame
Periprocedural

Secondary outcomes

1

Device usability

Evaluate clinical usability, assessed through customized questionnaires measuring clinician satisfaction, perceived ease of use, and integration of the devices into the procedural workflow.

Time frame
Periprocedural

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: